Top stories in endocrinology: Repeat neck ultrasounds ‘should be avoided’ for patients with thyroid cancer; adults with diabetes, chronic kidney disease have lower eGFR over time

Among the top stories in endocrinology were a study that found surveillance in patients being treated for thyroid cancer can safely be based on periodic serum thyroglobulin assays without the routine use of neck ultrasound if the initial imaging assessment reveals no evidence of disease. Another study suggested that adults with diabetes and stage 3 chronic kidney disease will experience consistently lower estimated glomerular filtration rates over time despite having normal albuminuria status.

Other highlights included Abbott releasing a point-of-care diagnostic tool for diabetes and two Q&As, one about screening for nonalcoholic fatty liver disease as a complication of type 2 diabetes and the other focusing on thyroid disease in pregnancy.

Repeat neck ultrasounds ‘should be avoided’ after treatment for most thyroid cancers

Among patients with low- or intermediate-risk differentiated thyroid cancer who underwent thyroidectomy, surveillance can safely be based on periodic serum thyroglobulin assays without the routine use of neck ultrasound if the initial imaging assessment reveals no evidence of disease, according to a retrospective analysis published in The Journal of Clinical Endocrinology & Metabolism. Read more.

Two eGFR paths emerge in diabetes with chronic kidney disease and normoalbuminuria

Adults with diabetes and stage 3 chronic kidney disease will experience consistently lower estimated glomerular filtration rates over time despite having normal albuminuria status, according to findings published in Diabetes Care. Read more.

Abbott releases point-of-care diagnostic tool for diabetes

Abbott announced the release of its Afinion HbA1c Dx assay, a rapid point-of-care test that measures HbA1c and can be used for diabetes diagnosing, monitoring and management, according to a press release from the company. Read more.

Clinicians should screen for nonalcoholic fatty liver disease as a complication of type 2 diabetes

Prevalence of nonalcoholic fatty liver disease — and its more severe stage, nonalcoholic steatohepatitis, or NASH, in particular — is increasing in developed countries. The condition has surpassed alcoholism as a cause of cirrhosis and will soon be the primary cause of liver transplantation in the United States, exceeding hepatitis C, according to Kenneth Cusi, MD, FACP, FACE, chief of the division of endocrinology, diabetes and metabolism at University of Florida. Read more.

Recommendations for managing thyroid disease in pregnancy

Thyroid disease is the second-most common endocrine disorder among women of reproductive age, and endocrinologists managing women with thyroid disease must consider several important points when developing a treatment plan before, during and after pregnancy, according to Caroline Nguyen, MD, assistant professor of clinical medicine at Keck School of Medicine at USC. Read more.

Among the top stories in endocrinology were a study that found surveillance in patients being treated for thyroid cancer can safely be based on periodic serum thyroglobulin assays without the routine use of neck ultrasound if the initial imaging assessment reveals no evidence of disease. Another study suggested that adults with diabetes and stage 3 chronic kidney disease will experience consistently lower estimated glomerular filtration rates over time despite having normal albuminuria status.

Other highlights included Abbott releasing a point-of-care diagnostic tool for diabetes and two Q&As, one about screening for nonalcoholic fatty liver disease as a complication of type 2 diabetes and the other focusing on thyroid disease in pregnancy.

Repeat neck ultrasounds ‘should be avoided’ after treatment for most thyroid cancers

Among patients with low- or intermediate-risk differentiated thyroid cancer who underwent thyroidectomy, surveillance can safely be based on periodic serum thyroglobulin assays without the routine use of neck ultrasound if the initial imaging assessment reveals no evidence of disease, according to a retrospective analysis published in The Journal of Clinical Endocrinology & Metabolism. Read more.

Two eGFR paths emerge in diabetes with chronic kidney disease and normoalbuminuria

Adults with diabetes and stage 3 chronic kidney disease will experience consistently lower estimated glomerular filtration rates over time despite having normal albuminuria status, according to findings published in Diabetes Care. Read more.

Abbott releases point-of-care diagnostic tool for diabetes

Abbott announced the release of its Afinion HbA1c Dx assay, a rapid point-of-care test that measures HbA1c and can be used for diabetes diagnosing, monitoring and management, according to a press release from the company. Read more.

Clinicians should screen for nonalcoholic fatty liver disease as a complication of type 2 diabetes

Prevalence of nonalcoholic fatty liver disease — and its more severe stage, nonalcoholic steatohepatitis, or NASH, in particular — is increasing in developed countries. The condition has surpassed alcoholism as a cause of cirrhosis and will soon be the primary cause of liver transplantation in the United States, exceeding hepatitis C, according to Kenneth Cusi, MD, FACP, FACE, chief of the division of endocrinology, diabetes and metabolism at University of Florida. Read more.

Recommendations for managing thyroid disease in pregnancy

Thyroid disease is the second-most common endocrine disorder among women of reproductive age, and endocrinologists managing women with thyroid disease must consider several important points when developing a treatment plan before, during and after pregnancy, according to Caroline Nguyen, MD, assistant professor of clinical medicine at Keck School of Medicine at USC. Read more.